TNFRSF13C and B-cell chronic lymphocytic leukemia: With a new actionable target, we will begin to amour BAFF‐R CAR T cells with supportive molecules that can either ameliorate T‐cell exhaustion or combat the immunosuppressive tumor microenvironment associated with CLL.